Die folgenden Begriffe wurden einbezogen:
antineoplastisch, antineoplastic, 抗新生物性
-
2012,
Miyakoshi Y, Kajihara C, Shimizu H, Yanagisawa H
Mutat Res Genet Toxicol Environ Mutagen 747 (1): 138-141
-
2012,
Raffa V, Riggio C, Smith MW, Jordan KC, Cao W, Cuschieri A
Technol Cancer Res Treat 11 (5): 459-465
-
2012,
Sun RG, Chen WF, Qi H, Zhang K, Bu T, Liu Y, Wang SR
Gen Physiol Biophys 31 (1): 1-10
-
2012,
Golberg A, Rubinsky B
Technol Cancer Res Treat 11 (2): 189-201
-
Bioelectromagnetics 33 (2): 106-123
-
2011,
Liu Y, Qi H, Sun RG, Chen WF
Tumori 97 (3): 386-392
-
2011,
Rihova B, Etrych T, Sirova M, Tomala J, Ulbrich K, Kovar M
J Drug Target 19 (10): 890-899
-
2011,
Jia D, Rao W, Wang C, Jin C, Wang S, Chen D, Zhang M, Guo J, Chang Z, Liu J
Int J Hyperthermia 27 (3): 275-285
-
2011,
Hao Q, Wenfang C, Xia A, Qiang W, Ying L, Kun Z, Runguang S
Bioelectromagnetics 32 (3): 191-199
-
2011,
Shen H, Li XD, Wu CP, Yin YM, Wang RS, Shu YQ
Int J Hyperthermia 27 (1): 27-32
-
2010,
Schneiderman RS, Shmueli E, Kirson ED, Palti Y
BMC Cancer 10: 229
-
2010,
de Campos VE, Teixeira CA, da Veiga VF, Ricci Jr E, Holandino C
Int J Nanomedicine 5: 961-971
-
2010,
Chen WF, Qi H, Sun RG, Liu Y, Zhang K, Liu JQ
Cancer Biother Radiopharm 25 (4): 401-408
-
2010,
Orel VE, Dziatkovs'ka II, Nikolov MO, Romanov AV, Mel'nyk IuH, Dziatkovs'ka NM
Klin Khir (7): 56-59
-
2010,
Gurbuz N, Sirav B, Yuvaci HU, Turhan N, Coskun ZK, Seyhan N
Electromagn Biol Med 29 (3): 98-104
-
2010,
Kaszuba-Zwoinska J, Wojcik K, Bereta M, Ziomber A, Pierzchalski P, Rokita E, Marcinkiewicz J, Zaraska W, Thor P
J Physiol Pharmacol 61 (2): 201-205
-
2010,
Huilgol NG, Gupta S, Dixit R
Int J Hyperthermia 26 (1): 21-25
-
2010,
Zhijian C, Xiaoxue L, Yezhen L, Shijie C, Lifen J, Jianlin L, Deqiang L, Jiliang H
Mutat Res Genet Toxicol Environ Mutagen 695 (1-2): 16-21
-
2009,
Nomikou N, McHale AP
Cancer Lett 279 (2): 202-208
-
2008,
Ruiz-Gomez MJ, Merino-Moyano MD, Cebrian-Martin MG, Prieto-Barcia MI, Martinez-Morillo M
Electromagn Biol Med 27 (3): 289-297
-
Hell J Nucl Med 11 (2): 122-123
-
Hell J Nucl Med 11 (2): 122
-
Hell J Nucl Med 11 (2): 122
-
2008,
Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, Miklavcic D, Kadivec M, Kranjc S, Secerov A, Cemazar M
Br J Cancer 98 (2): 388-398
-
2008,
Girgert R, Gründker C, Emons G, Hanf V
Bioelectromagnetics 29 (3): 169-176